The analysis of publicly available genomic datasets shows that the frequency of HER2 alterations in CRC ranges from ~6% of colon adenocarcinomas to ~7.5% of rectal carcinomas, with a particularly high frequency in the mucinous histological subtype (Figure 1). The gene discussed is ERBB2; the disease is colorectal carcinoma.